LAXAF — Laxai Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $1.46m
Annual balance sheet for Laxai Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.699 | 0.361 | 0.001 | 0.004 | 0.002 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.01 | 4.29 | 0.402 | 0 | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6.76 | 7.67 | 0.403 | 0.004 | 0.002 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.6 | 2.2 | 0.005 | 0.005 | 0.005 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 12.4 | 14.1 | 0.574 | 0.093 | 0.007 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.56 | 5.05 | 0.65 | 1.04 | 1.35 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.58 | 6.78 | 0.65 | 1.04 | 1.35 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 6.79 | 7.32 | -0.076 | -0.944 | -1.35 |
Total Liabilities & Shareholders' Equity | 12.4 | 14.1 | 0.574 | 0.093 | 0.007 |
Total Common Shares Outstanding |